Trending:
Weight-loss drug for sleep apnea approved: Health Canada | CBC News

Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing tempor...

The Japan Times
The Japan Times

www.japantimes.co.jp




See also: